Modified endothelial cells for the treatment of graft vasculopathy;Modifizierte endothelzellen bei graftvaskulopathie

Zeitschrift fur Kardiologie

Volumn 90, Issue 12, 2001, Pages 939-945

  Haverich, A ^a   Kallenbach, K ^a  

^a Leibniz Forschungslaboratorien für Biotechnologie und künstliche Organe   (Germany)

Author keywords

Endothelial cells; Gene therapy; Intima hyperplasia; Tissue engineering; Vasculopathy

Indexed keywords

MATRIX METALLOPROTEINASE; NITRIC OXIDE;

ANIMAL MODEL; ARTERIAL PRESSURE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL INJURY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; GENE OVEREXPRESSION; GENE THERAPY; GRAFT OCCLUSION; HEART MUSCLE REVASCULARIZATION; HEART TRANSPLANTATION; TISSUE ENGINEERING; VASCULAR DISEASE; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS; CORONARY ARTERY BYPASS; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; FIBROMUSCULAR DYSPLASIA; GENE THERAPY; GRAFT OCCLUSION, VASCULAR; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; POSTOPERATIVE COMPLICATIONS; TISSUE ENGINEERING;

EID: 0035690029     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920170064     Document Type: Article

References (44)

1. Transforming growth factor beta in relation to cardiac allograft vasculopathy after heart transplantation
2. Tissue engineering of heart valves - Human endothelial cell seeding of detergent acellularized porcine valves
3. Engineering of human vascular aortic tissue based on a xenogenic starter matrix
4. Mid-term results of heart transplantation, cardiomyoplasty, and medical treatment of refractory heart failure caused by idiopathic dilated cardiomyopathy
5. Role of vascular endothelial cells in allograft response
6. Atherosclerosis and the late closure of aortocoronary saphenous vein grafts: Sequentiell studies at 2 weeks, 1 year, 5-7 years, and 10-12 years after surgery
7. Donor ACE gene polymorphism: A genetic risk factor for accelerated coronary sclerosis following cardiac transplantation
8. Structural and functional consequences of bypass grafting with autologeous vein
9. Vein to artery grafts: A morphological and histochemical study of the histogenesis of intimal hyperplasia
10. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin 1 receptors
11. Inhibition of endothelial cell migration by gene transfer of tissue inhibitor of metalloproteinase-1
12. Modulation of matrix metalloproteinase activity in human vein grafts using adenovirus-mediated gene transfer
13. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell function in vitro and in vivo
14. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions
15. Nitric oxide-generating vasodilatators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
16. Adeno-virus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein
17. Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3
18. Functional living trileaflet heart valves grown in vivo
19. Cardiac allograft vasculopathy: Current concepts, recent development, and future directions
20. Role of Stromelysin-1 (MMP-3) and tissue inhibitor of metalloproteinase 1 (TIMP-1) in vascular remodelling
21. Gene therapy for attenuatting cardiac allograft arteriopathy using ex vivo E2F decoy transfection by HVJ-AVE-liposome method in mice and non-human primates
22. Tissue engineering
23. Arterial graft patency in coronary artery bypass grafting; what do we really know?
24. Aorto-coronary saphenous vein graft disease - Pathogenesis, predisposition, and prevention
25. Koronare vaskulopathie nach herztransplantation - Einfluss von zeitlichem auftreten, schweregrad und progredienz auf die prognose im langzeitverlauf
26. ACE-polymorphism is associated with the development of allograft vascular disease in heart transplant recipients
27. Tumor-necrosis-factor polymorphism and development of allograft vascular disease after heart transplantation
28. Cardiac allograft vascular disease after orthotopic heart transplantation - Methylenetetrahydrofolate reductase gene polymorphism C677T does not account for rapidly progressive form
29. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium
30. Cardiac valve endothelial cells: Relevance in the long-term function of biologic valve prothesis
31. Early in vivo experience with tissue engineered trileaflet heart valves
32. Upregulation of basement membrane-degrading metalloproteinase secretion after ballon injury of pig carotid arteries
33. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits
34. Total arterial revascularization with an internal thoracic artery and radial artery T graft
35. Decoy against nuclear factor-kappa B attenuates myocardial cell infiltraion and arterial neointimal formation in murine cardiac allografts
36. Tissue engineering of vascular grafts: Human cell seeding of decellularised porcine matrix
37. Endothelial cell injury in cardiovascular surgery
38. Gene therapy inhibiting neointimal vascular lesion: In vivo gene transfer of endothelial cell nitric oxide synthase gene
39. Endothelial cell seeding of deendothelialised human arteries: Improvement by adhesion molecule induction and flow-seeding technology
40. Improved endothelial cell attachement on ePTFE vascular grafts pretreated with sythetic RGD-containing peptides
41. Cardiac allograft vasculopathy. A review
42. Coronary artery disease in the transplanted heart
43. Complete arterial revascularization in multivessel coronary artery disease with 2 conduits (skeletonized grafts and T grafts)